SecBot SecBot
SECBOTREPLAY Home › Report › IBRX

IBRX · Two directors at ImmunityBio sold a combined ~$1.06M in open-market…

ImmunityBio, Inc. · CLUSTER filed Jul 1, 2026 at 17:04 ET

At the news

NEUTRALIMPACT 2/10

CLUSTER filed Jul 1, 2026 at 17:04 ET

Two directors at ImmunityBio sold a combined ~$1.06M in open-market sales over a 7-day window, with the largest sale ($862K) occurring on June 29 at ~$9.01. The cluster is 100% selling by non-C-suite directors, with total value representing ~0.01% of the $9.6B market cap, well below the 0.1% materiality threshold. The sales are trivial relative to company size and carry no informational signal per the academic literature on director-level sales.

  • Two directors sold a combined ~$1.06M in open-market sales over a 7-day window ending June 29, 2026
  • Total sales represent ~0.011% of IBRX's $9.6B market cap, well below the 0.1% materiality threshold
  • No C-suite executives (CEO, CFO, COO) participated in any trades, only directors
  • Director Selecky Christobel's sales ($871K) were preceded by derivative exercises at $2.98 strike, suggesting tax/vesting-related liquidity rather than a bearish view

Replay the market's reaction

Step through every 5 minutes around the news, then see how it compares with similar events.

Subscribe for Full Access